Li Jun Z, Vawter Marquis P, Walsh David M, Tomita Hiroaki, Evans Simon J, Choudary Prabhakara V, Lopez Juan F, Avelar Abigail, Shokoohi Vida, Chung Tisha, Mesarwi Omar, Jones Edward G, Watson Stanley J, Akil Huda, Bunney William E, Myers Richard M
Department of Genetics, Stanford University School of Medicine, California 94305, USA.
Hum Mol Genet. 2004 Mar 15;13(6):609-16. doi: 10.1093/hmg/ddh065. Epub 2004 Jan 20.
Studies of gene expression abnormalities in psychiatric or neurological disorders often involve the use of postmortem brain tissue. Compared with single-cell organisms or clonal cell lines, the biological environment and medical history of human subjects cannot be controlled, and are often difficult to document fully. The chance of finding significant and replicable changes depends on the nature and magnitude of the observed variations among the studied subjects. During an analysis of gene expression changes in mood disorders, we observed a remarkable degree of natural variation among 120 samples, which represented three brain regions in 40 subjects. Most of such diversity can be accounted for by two distinct expression patterns, which in turn are strongly correlated with tissue pH. Individuals who suffered prolonged agonal states, such as with respiratory arrest, multi-organ failure or coma, tended to have lower pH in the brain; whereas those who experienced brief deaths, associated with accidents, cardiac events or asphyxia, generally had normal pH. The lower pH samples exhibited a systematic decrease in expression of genes involved in energy metabolism and proteolytic activities, and a consistent increase of genes encoding stress-response proteins and transcription factors. This functional specificity of changed genes suggests that the difference is not merely due to random RNA degradation in low pH samples; rather it reflects a broad and actively coordinated biological response in living cells. These findings shed light on critical molecular mechanisms that are engaged during different forms of terminal stress, and may suggest clinical targets of protection or restoration.
对精神或神经疾病中基因表达异常的研究通常涉及使用死后脑组织。与单细胞生物或克隆细胞系相比,人类受试者的生物环境和病史无法得到控制,而且往往难以全面记录。发现显著且可重复变化的机会取决于所研究受试者中观察到的变异的性质和程度。在对情绪障碍中基因表达变化的分析中,我们在120个样本中观察到了显著程度的自然变异,这些样本代表了40名受试者的三个脑区。这种多样性大多可由两种不同的表达模式来解释,而这两种模式又与组织pH值密切相关。经历过长时间濒死状态(如呼吸骤停、多器官衰竭或昏迷)的个体,其大脑中的pH值往往较低;而那些因事故、心脏事件或窒息导致短时间死亡的个体,其pH值通常正常。pH值较低的样本中,参与能量代谢和蛋白水解活性的基因表达出现系统性下降,而编码应激反应蛋白和转录因子的基因则持续增加。基因变化的这种功能特异性表明,这种差异不仅仅是由于低pH值样本中随机的RNA降解;相反,它反映了活细胞中广泛且积极协调的生物学反应。这些发现揭示了在不同形式的终末应激过程中所涉及的关键分子机制,并可能提示保护或恢复的临床靶点。